GINA FRIES: Open Payments
NPI 1881685253 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,176 in 38 payments from 5 companies in 2025. Trend: 2023 $23,893 · 2024 $42,132 · 2025 $23,176
Speaker / faculty: $19,846Travel & lodging: $2,018Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $22,733 |
| GENZYME CORPORATION | 1 | $127 |
| Karyopharm Therapeutics Inc. | 1 | $115 |
| Pharmacosmos Therapeutics Inc. | 1 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
Products named: RYBREVANT, DARZALEX, TECVAYLI, SARCLISA, XPOVIO, MONOFERRIC, TALVEY.
Industry payments across NY — which companies pay providers there.
